Robert Ticktin
Vermögen: 119 421 $ am 31.08.2026
Vermögen: 119 421 $ am 31.08.2026
Mr. Robert Ticktin is a COO, Secretary & General Counsel at PMV Pharmaceuticals, Inc. Mr. Ticktin was previously employed as an Associate General Counsel by Tesaro, Inc., a Senior Vice President & General Counsel by EPIRUS Biopharmaceuticals, Inc. /Old/, a Secretary, Senior Vice President & General Counsel by EPIRUS Biopharmaceuticals, Inc., and a Senior Vice President & General Counsel by Zalicus, Inc. He received his undergraduate degree from The Ohio State University and a graduate degree from Fordham University School of Law.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 07.04.2026 | 98’695 ( 0.18% ) | 119 421 $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| PMV PHARMACEUTICALS, INC. | Geschäftsführer | 01.12.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
| TESARO INC | Corporate Officer/Principal | 01.06.2020 |
EPIRUS Biopharmaceuticals, Inc. /Old/
EPIRUS Biopharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops monoclonal antibodies | General Counsel | 01.08.2016 |
| EPIRUS BIOPHARMACEUTICALS, INC. | General Counsel | - |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceutical products for patients suffering from pain and immuno-inflammatory diseases | General Counsel | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceutical products for patients suffering from pain and immuno-inflammatory diseases | Health Technology |
EPIRUS Biopharmaceuticals, Inc. /Old/
EPIRUS Biopharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops monoclonal antibodies | Health Technology |
Fordham University School of Law
Fordham University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EPIRUS Biopharmaceuticals, Inc.
EPIRUS Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes biosimilar monoclonal antibodies | Health Technology |
PMV Pharmaceuticals, Inc.
PMV Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in discovery and development of small molecule, tumor-agnostic therapies targeting p53 | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen